DNA Sequencing to Detect Residual Disease in Adults With Acute Myeloid Leukemia Prior to Hematopoietic Cell TransplantLaura W. Dillon, Christopher S. Hourigan, Gege Gui et al.|JAMA|2023Cited by 147
Measurable Residual <i>FLT3</i> Internal Tandem Duplication Before Allogeneic Transplant for Acute Myeloid LeukemiaLaura W. Dillon, Christopher S. Hourigan, Jake Higgins et al.|JAMA Oncology|2024Cited by 58
Pre-MEASURE: Multicenter evaluation of the prognostic significance of measurable residual disease testing prior to allogeneic transplantation for adult patients with AML in first remission.Chris S. Hourigan, Kristin Page, Laura W. Dillon et al.|Journal of Clinical Oncology|2022Cited by 11
Measurable residual mutated IDH2 before allogeneic transplant for acute myeloid leukemiaGege Gui, Christopher S. Hourigan, Niveditha Ravindra et al.|Bone Marrow Transplantation|2024Cited by 10
Measurable residual mutated IDH1 before allogeneic transplant for acute myeloid leukemiaGege Gui, Christopher S. Hourigan, Niveditha Ravindra et al.|Bone Marrow Transplantation|2024Cited by 10